March 15, 2026 · Form 4 insider transaction
Farrow Jeffrey S sold 8,020 shares of TARS at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock.; RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service.